MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
63.30
+1.43
+2.31%
After Hours: 63.31 +0.01 +0.02% 19:35 12/05 EST
OPEN
62.04
PREV CLOSE
61.87
HIGH
64.40
LOW
61.25
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
111.29
52 WEEK LOW
47.25
MARKET CAP
4.20B
P/E (TTM)
26.59
1D
5D
1M
3M
1Y
5Y
1D
3 of Wall Street’s Favorite Stocks to Keep an Eye On
Barchart · 2d ago
Weekly Report: what happened at LNTH last week (1124-1128)?
Weekly Report · 6d ago
Jefferies Sticks to Their Buy Rating for Lantheus (LNTH)
TipRanks · 11/24 13:56
Lantheus to Present New Florbetaben F18 Data at CTAD 2025
Reuters · 11/24 13:30
Weekly Report: what happened at LNTH last week (1117-1121)?
Weekly Report · 11/24 09:33
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know
Barchart · 11/21 17:44
1 Oversold Stock Ready to Bounce Back and 2 We Avoid
Barchart · 11/19 07:04
Weekly Report: what happened at LNTH last week (1110-1114)?
Weekly Report · 11/17 09:34
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.